Page 3 - Cancer

Most cancer drugs beyond ambit of price control mechanisms: Parl panel

A Parliamentary panel has flagged that a substantial segment of cancer drugs are still beyond the ambit of current price control mechanisms and recommended measures to include the widest possible range of cancer drugs by expanding the scope of the Drugs Prices Control Order. In its 163rd report presented on Wednesday, the Committee on Petitions, Rajya Sabha, headed by Narain Dass Gupta stressed that regular and comprehensive market assessments should be instituted to monitor prevailing drug prices and availability trends. Though significant steps have been taken in recent years towards strengthening the regulatory framework for governing the pricing of cancer drugs and promote affordability, a substantial segment of such drugs still remain beyond the ambit of current price control mechanisms, it said. The Committee noted that with the notification of NLEM, 2022, the number of anti-cancer medicines under price control has increased from 40 (in 2011) to 63 (in 2022). However, a ...

Frank Caprio, America's 'nicest judge,' dies at 88 after battle with cancer

Beloved for his compassion on Caught in Providence, Judge Frank Caprio inspired millions with his humane approach to justice

Respiratory viruses like flu, coronavirus may trigger cancer relapse: Study

A new study reveals that respiratory infections like common flu and coronavirus can awaken dormant breast cancer cells in the lungs, raising concerns for survivors

AI eroded doctors' ability to detect cancer within months in study

AI helped health professionals to better detect pre-cancerous growths in the colon, but when the assistance was removed, their ability to find tumors dropped by about 20 per cent

Cannabis addiction triples oral cancer risk in just five years, study finds

A new California study reveals that cannabis use disorder is linked to a threefold rise in oral cancer risk, challenging the belief that marijuana is a 'safe' drug

7,000 steps a day - that's all it takes to outwalk heart disease, says study

A global study finds that walking 7,000 steps daily can significantly reduce the risk of death by heart disease, diabetes, dementia and more, offering a practical alternative to the 10,000-step target

Scientists develop AI system that can predict liver cancer recurrence

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally

Study links muscle weakness in cancer survivors to treatable vessel issues

Muscle loss in cancer patients is a major health problem, but the exact causes of how precisely tumors affect muscles remain an active area of research

Glenmark Pharma's unit, Abbvie sign global licensing deal for cancer drug

Under the agreement, AbbVie will get exclusive rights to develop, manufacture and commercialize ISB 2001 in North America, Europe, Japan and Greater China

Stomach cancer: Study warns 1.6 million Indians born after 2008 at risk

lobal estimate links 76 per cent of projected lifetime cases to H. pylori and urges mass screening, with India expected to see over 1.6 million cases

Could this tiny genetic mutation be making humans more prone to cancer?

A mutation in the immune protein FasL may make humans more vulnerable to solid tumours, but scientists say it could be fixed through combination immunotherapy

This is what 'magic mushrooms' do to cancer patients with depression

A new study finds that psilocybin, the hallucinogenic compound in magic mushrooms, can offer long-term relief from depression and anxiety in cancer patients

Alembic Pharma gets USFDA nod for generic cancer treatment injection

Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Healthcare Corporation, it added. Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of ovarian Cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma, the company said. Citing IQVIA data, Alembic said Doxorubicin Hydrochloride Liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2mg/mL) single-dose ...

HPV key factor for rise in cancer cases among Indian youth, say doctors

A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major contributing factor in the rise of cancers in young Indians, particularly among those in their twenties and thirties. With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis if urgent measures are not implemented. Dr Ashish Gupta, Chief of Medical Oncology at Amerix Cancer Hospital, New Delhi, said, "HPV-related cancers are striking far earlier than we used to see. Patients in their twenties are coming in with cervical, oral, and throat cancers -- many of which could have been avoided entirely with timely vaccination and proper awareness." "What's most heartbreaking is that HPV is preventable, yet many families and individuals are not even aware of the risk," Dr Gupta said. Unlike other cancers that develop over decades, HPV-related cancers in young people often .

Sun Pharma partner Philogen withdraws EU application for skin cancer drug

Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback

Kidney cancer risk: Doctor-approved prevention tips for every age

Kidney cancer often starts with habits built in your 20s and 30s-doctors explain how to lower your risk through simple lifestyle changes

This new blood test could spot cancer up to 3 years before symptoms

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially transforming early treatment and survival rates

World Blood Donor Day 2025: Know the date, history, significance and more

World Blood Donor Day 2025: World Donor Day is observed every year on June 14 to recall the importance of blood donation for the healthcare system across the world

BioNtech to buy CureVac in $1.25 billion share deal to boost cancer focus

CureVac about a year ago opted to focus on oncology when it agreed to sell its remaining influenza and COVID-19 vaccine development to its alliance partner, Britain's GSK

Tata Memorial Centre ties up with Wipro GE to set up cancer research centre

Tata Memorial Centre has tied up with Wipro GE HealthCare Technologies Inc to establish a Cancer Research & Innovation Centre. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group' to determine key project areas and a collaboration roadmap for the next five years, Tata Memorial Centre (TMC) said in a statement. "The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of daycare centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge," Tata Memorial Hospital Director CS Pramesh stated. With Wipro GE HealthCare, TMC aims to enhance clinical research and promote academic engagement to transform personalised cancer care for improved outcomes cancer care, he added. "With this partnership, we strengthen our commitment to connect ...